Norwalk-like viruses (NLVs) are single-stranded, positive-sense RNA viruses that cause acute gastroenteritis in humans. The viruses are highly contagious, resistant to environmental conditions, and spread quickly by surface contact or person-to-person transmission. NLVs commonly cause large food- and water-borne outbreaks in a variety of settings, both civilian and military. NLVs have been difficult to study due to the lack of cell culture and animal models. There is no treatment available for NLV infection and the high genetic and antigenic diversity of NLVs makes it difficult to prevent the disease by a vaccination. We have recently observed that the prototype Norwalk virus (NV) uses the human histo-blood group antigens as receptors for infection. This discovery opens a way to develop strategies to control NLV disease. Extended studies showed that different NLVs recognize different receptors defined by secretor, Lewis, and ABO types. Glycoconjugates containing these major histo-blood epitopes were found to be responsible for NLV binding and similar glycoconjugates found in human milk protected breast-fed infants from NLV infection. Thus, human histo-blood group antigens play a critical role in the host specificity to NLV infection. Inhibitors that block NLV attachment/entry to intestinal epithelial cells may be developed as an effective antiviral drug against NLVs. Towards this future goal, the following three specific aims are proposed.
Specific aim 1. To characterize the genetic variability of Norwalk-like viruses (NLVs) and their binding to human histo-blood group antigens for extended strain diversity.
Specific aim 2. To map the domain(s) of NLV capsids that bind to human histo-blood group antigens by computer modeling and biochemistry approaches.
Specific aim 3. To determine the crystal structure of NLV capsid and sub-capsid units in the presence and absence of human histo-blood group antigens. ? ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI055649-04
Application #
7348342
Study Section
Virology Study Section (VR)
Program Officer
Berard, Diana S
Project Start
2005-08-01
Project End
2010-01-31
Budget Start
2008-02-01
Budget End
2009-01-31
Support Year
4
Fiscal Year
2008
Total Cost
$313,931
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Dai, Ying-Chun; Zhang, Xu-Fu; Xia, Ming et al. (2015) Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera. PLoS One 10:e0124945
Jin, Miao; Tan, Ming; Xia, Ming et al. (2015) Strain-specific interaction of a GII.10 Norovirus with HBGAs. Virology 476:386-94
Tan, Ming; Jiang, Xi (2014) Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert Rev Mol Med 16:e5
Wei, Chao; Meller, Jarek; Jiang, Xi (2013) Substrate specificity of Tulane virus protease. Virology 436:24-32
Fan, Qiang; Wei, Chao; Xia, Ming et al. (2013) Inhibition of Tulane virus replication in vitro with RNA interference. J Med Virol 85:179-86
Zhang, Xu-Fu; Tan, Ming; Chhabra, Monica et al. (2013) Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections. PLoS One 8:e69379
Dai, Ying-Chun; Zhang, Xu-Fu; Tan, Ming et al. (2013) A dual chicken IgY against rotavirus and norovirus. Antiviral Res 97:293-300
Fang, Hao; Tan, Ming; Xia, Ming et al. (2013) Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One 8:e63269
Liu, Yang; Huang, Pengwei; Jiang, Baoming et al. (2013) Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants. PLoS One 8:e78113
Liu, Yang; Huang, Pengwei; Tan, Ming et al. (2012) Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol 86:9899-910

Showing the most recent 10 out of 35 publications